AAPS announces 2025 Best Poster Awards
Recipients’ research examines impact of microgravity on muscle aging, new approaches to treating breast cancer, and digital twin applications in preclinical development.
AAPS is proud to announce that three PharmSci 360 posters have been recognized as Best Posters for 2025.
The Best Poster Award goes to the posters that are considered the most scientifically impactful by members of the Scientific Advisory Committee.
This year’s Best Poster Award recipients are:
- “Extracellular Vesicle Transcriptomic Analysis for Understanding Muscle Aging under the Influence of Microgravity“, Samantha S Ali, University of Florida (FL, USA).
- “Discovery of Mitochondria Targeted Non-apoptotic Cell Death Inducers against Resistant Triple-Negative Breast Cancer“, Saloni Sood, University of Arkansas for Medical Sciences (AR, USA).
- “A Novel Approach to Preclinical Drug Development Using Digital Twins of Ex Vivo Human Lungs“, Xuanzi Zhou, University Health Network (Toronto, Canada).
“Presenting my research through posters and having the opportunity to interact with like-minded scientists was instrumental in the early stages of my career,” said Parag Kolhe, PhD, Chair of the 2025 PharmSci 360 Abstract Screening Committee.
“Congratulations to these award recipients on their achievements, and I look forward to seeing further scientific advancements showcased this November at PharmSci 360.”
On Monday, November 10, at PharmSci 360, AAPS 2025 President Russell Weiner, PhD, FAAPS, will host the Best Poster Award Special Poster Collection (9:30–10:25 am, Poster Forum #4, in the Solution Center). The Best Poster Award recipients will present their posters and take questions about their research.
PharmSci 360 takes place November 9–12, in San Antonio (TX, USA), at the Henry B. Gonzalez Convention Center. For more information, visit www.aaps.org/register.
More content from AAPS
- AAPS Elevates Eight Members to Fellow Status
- AAPS Supports Credible Science in Pharmaceutical Research Literature
- Healthcare, Finance and Smart Materials Experts Deliver Opening and Closing Plenaries at PharmSci 360
- AAPS 2025 Summer Scientific Forum round-up
About AAPS
The American Association of Pharmaceutical Scientists (AAPS) is a 501(c)(3) non-profit association of more than 7,000 scientists and professionals employed in academia, industry, regulatory and other research related to the pharmaceutical sciences worldwide. Its mission is to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health, which members pursue through four peer-reviewed journals and a variety of events in person and online. www.aaps.org
AAPS journals publish articles covering the breadth of pharmaceutical science, including complementary disciplines like chemistry, biology, and engineering. AAPS publishes four peer-reviewed journals: The AAPS Journal, AAPS PharmSciTech, Pharmaceutical Research, and AAPS Open. The latter is AAPS’ first fully open-access journal. It is freely available worldwide, and authors retain copyright. All four are available with AAPS membership or through institutional access. www.aaps.org/journals
In association with:
